The global Exosome Proteomics Service market was valued at US$ 541 million in 2025 and is anticipated to reach US$ 804 million by 2032, at a CAGR of 5.8% from 2026 to 2032.

Exosome Proteomics Service Market

To address the challenges of high technical barriers, complex sample processing, and low efficiency in biomarker screening in exosome proteomics research, exosome proteomics services have emerged. Since the rise of exosome research and the innovation of mass spectrometry technology in the early 21st century, this service field has achieved rapid improvement and standardization of its technical system. Currently, exosome proteomics services have developed into a complete solution integrating ultracentrifugation, size exclusion chromatography, mass spectrometry identification, and bioinformatics analysis, covering multi-level analyses such as label-free quantification, TMT/iTRAQ labeled quantification, and targeted validation. It is widely applied in cutting-edge fields such as early disease biomarker discovery, drug mechanism research, tumor microenvironment analysis, stem cell function assessment, and the development of novel drug delivery systems. It can systematically reveal the key protein information carried by exosomes, providing high-value in-depth data support for precision medicine, new drug development, and basic life science research.

Exosome proteomics services are accelerating their transformation from research tools to clinical applications, with technological breakthroughs (such as high-purity preparation and high-throughput analysis) and industrial collaboration (such as upstream and downstream linkages) being the core driving forces. In the future, the focus should be on three major areas: the construction of standardized systems, the development of engineered exosomes, and the expansion of clinical application scenarios, to achieve a leapfrog development from "basic research" to "clinical application," ultimately promoting the comprehensive upgrade of precision medicine and personalized treatment.

This report delivers a comprehensive overview of the global Exosome Proteomics Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Exosome Proteomics Service. The Exosome Proteomics Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Exosome Proteomics Service market comprehensively. Regional market sizes by Type, by Application, by Technical Methods, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Exosome Proteomics Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Exosome Proteomics Service Market Report

Report Metric	Details
Report Name	Exosome Proteomics Service Market
Accounted market size in 2025	US$ 541 million
Forecasted market size in 2032	US$ 804 million
CAGR	5.8%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Separation Identification and Characterization Quantitative Analysis Content Analysis Functional Analysis
Segment by Technical Methods	Mass Spectrometry-driven Non-mass Spectrometry-dependent
Segment by Analysis Granularity	Whole Proteome Scanning Targeted Sub-proteome
Segment by Application	Financial Industry Government Sector Media Organizations E-commerce and Retail Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	System Biosciences, HansaBioMed Life Sciences, QIAGEN, Norgen Biotek, Bio-Techne, AMSBIO, NX Pharmagen, Thermo Fisher Scientific, Sistemic, Exosome Diagnostics, Lonza Group, Evox Therapeutics, Evomic Science, Optofluidics, New England Biolabs, Izon Science, Miltenyi Biotec, Codiak BioSciences, Ology Bioservices
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technical Methods, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Exosome Proteomics Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Exosome Proteomics Service Market growing?

Ans: The Exosome Proteomics Service Market witnessing a CAGR of 5.8% during the forecast period 2026-2032.

What is the Exosome Proteomics Service Market size in 2032?

Ans: The Exosome Proteomics Service Market size in 2032 will be US$ 804 million.

Who are the main players in the Exosome Proteomics Service Market report?

Ans: The main players in the Exosome Proteomics Service Market are System Biosciences, HansaBioMed Life Sciences, QIAGEN, Norgen Biotek, Bio-Techne, AMSBIO, NX Pharmagen, Thermo Fisher Scientific, Sistemic, Exosome Diagnostics, Lonza Group, Evox Therapeutics, Evomic Science, Optofluidics, New England Biolabs, Izon Science, Miltenyi Biotec, Codiak BioSciences, Ology Bioservices

What are the Application segmentation covered in the Exosome Proteomics Service Market report?

Ans: The Applications covered in the Exosome Proteomics Service Market report are Financial Industry, Government Sector, Media Organizations, E-commerce and Retail, Others

What are the Type segmentation covered in the Exosome Proteomics Service Market report?

Ans: The Types covered in the Exosome Proteomics Service Market report are Separation, Identification and Characterization, Quantitative Analysis, Content Analysis, Functional Analysis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Exosome Proteomics Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Separation

1.2.3 Identification and Characterization

1.2.4 Quantitative Analysis

1.2.5 Content Analysis

1.2.6 Functional Analysis

1.3 Market by Technical Methods

1.3.1 Global Exosome Proteomics Service Market Size Growth Rate by Technical Methods: 2021 vs 2025 vs 2032

1.3.2 Mass Spectrometry-driven

1.3.3 Non-mass Spectrometry-dependent

1.4 Market by Analysis Granularity

1.4.1 Global Exosome Proteomics Service Market Size Growth Rate by Analysis Granularity: 2021 vs 2025 vs 2032

1.4.2 Whole Proteome Scanning

1.4.3 Targeted Sub-proteome

1.5 Market by Application

1.5.1 Global Exosome Proteomics Service Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Financial Industry

1.5.3 Government Sector

1.5.4 Media Organizations

1.5.5 E-commerce and Retail

1.5.6 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Exosome Proteomics Service Market Perspective (2021–2032)

2.2 Global Exosome Proteomics Service Growth Trends by Region

2.2.1 Global Exosome Proteomics Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Exosome Proteomics Service Historic Market Size by Region (2021–2026)

2.2.3 Exosome Proteomics Service Forecasted Market Size by Region (2027–2032)

2.3 Exosome Proteomics Service Market Dynamics

2.3.1 Exosome Proteomics Service Industry Trends

2.3.2 Exosome Proteomics Service Market Drivers

2.3.3 Exosome Proteomics Service Market Challenges

2.3.4 Exosome Proteomics Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Exosome Proteomics Service Players by Revenue

3.1.1 Global Top Exosome Proteomics Service Players by Revenue (2021–2026)

3.1.2 Global Exosome Proteomics Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Exosome Proteomics Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Exosome Proteomics Service Revenue

3.4 Global Exosome Proteomics Service Market Concentration Ratio

3.4.1 Global Exosome Proteomics Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Exosome Proteomics Service Revenue in 2025

3.5 Global Key Players of Exosome Proteomics Service Head Offices and Areas Served

3.6 Global Key Players of Exosome Proteomics Service, Products and Applications

3.7 Global Key Players of Exosome Proteomics Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Exosome Proteomics Service Breakdown Data by Type

4.1 Global Exosome Proteomics Service Historic Market Size by Type (2021–2026)

4.2 Global Exosome Proteomics Service Forecasted Market Size by Type (2027–2032)

5 Exosome Proteomics Service Breakdown Data by Application

5.1 Global Exosome Proteomics Service Historic Market Size by Application (2021–2026)

5.2 Global Exosome Proteomics Service Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Exosome Proteomics Service Market Size (2021–2032)

6.2 North America Exosome Proteomics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Exosome Proteomics Service Market Size by Country (2021–2026)

6.4 North America Exosome Proteomics Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Exosome Proteomics Service Market Size (2021–2032)

7.2 Europe Exosome Proteomics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Exosome Proteomics Service Market Size by Country (2021–2026)

7.4 Europe Exosome Proteomics Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Exosome Proteomics Service Market Size (2021–2032)

8.2 Asia-Pacific Exosome Proteomics Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Exosome Proteomics Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Exosome Proteomics Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Exosome Proteomics Service Market Size (2021–2032)

9.2 Latin America Exosome Proteomics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Exosome Proteomics Service Market Size by Country (2021–2026)

9.4 Latin America Exosome Proteomics Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Exosome Proteomics Service Market Size (2021–2032)

10.2 Middle East & Africa Exosome Proteomics Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Exosome Proteomics Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Exosome Proteomics Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 System Biosciences

11.1.1 System Biosciences Company Details

11.1.2 System Biosciences Business Overview

11.1.3 System Biosciences Exosome Proteomics Service Introduction

11.1.4 System Biosciences Revenue in Exosome Proteomics Service Business (2021–2026)

11.1.5 System Biosciences Recent Development

11.2 HansaBioMed Life Sciences

11.2.1 HansaBioMed Life Sciences Company Details

11.2.2 HansaBioMed Life Sciences Business Overview

11.2.3 HansaBioMed Life Sciences Exosome Proteomics Service Introduction

11.2.4 HansaBioMed Life Sciences Revenue in Exosome Proteomics Service Business (2021–2026)

11.2.5 HansaBioMed Life Sciences Recent Development

11.3 QIAGEN

11.3.1 QIAGEN Company Details

11.3.2 QIAGEN Business Overview

11.3.3 QIAGEN Exosome Proteomics Service Introduction

11.3.4 QIAGEN Revenue in Exosome Proteomics Service Business (2021–2026)

11.3.5 QIAGEN Recent Development

11.4 Norgen Biotek

11.4.1 Norgen Biotek Company Details

11.4.2 Norgen Biotek Business Overview

11.4.3 Norgen Biotek Exosome Proteomics Service Introduction

11.4.4 Norgen Biotek Revenue in Exosome Proteomics Service Business (2021–2026)

11.4.5 Norgen Biotek Recent Development

11.5 Bio-Techne

11.5.1 Bio-Techne Company Details

11.5.2 Bio-Techne Business Overview

11.5.3 Bio-Techne Exosome Proteomics Service Introduction

11.5.4 Bio-Techne Revenue in Exosome Proteomics Service Business (2021–2026)

11.5.5 Bio-Techne Recent Development

11.6 AMSBIO

11.6.1 AMSBIO Company Details

11.6.2 AMSBIO Business Overview

11.6.3 AMSBIO Exosome Proteomics Service Introduction

11.6.4 AMSBIO Revenue in Exosome Proteomics Service Business (2021–2026)

11.6.5 AMSBIO Recent Development

11.7 NX Pharmagen

11.7.1 NX Pharmagen Company Details

11.7.2 NX Pharmagen Business Overview

11.7.3 NX Pharmagen Exosome Proteomics Service Introduction

11.7.4 NX Pharmagen Revenue in Exosome Proteomics Service Business (2021–2026)

11.7.5 NX Pharmagen Recent Development

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Details

11.8.2 Thermo Fisher Scientific Business Overview

11.8.3 Thermo Fisher Scientific Exosome Proteomics Service Introduction

11.8.4 Thermo Fisher Scientific Revenue in Exosome Proteomics Service Business (2021–2026)

11.8.5 Thermo Fisher Scientific Recent Development

11.9 Sistemic

11.9.1 Sistemic Company Details

11.9.2 Sistemic Business Overview

11.9.3 Sistemic Exosome Proteomics Service Introduction

11.9.4 Sistemic Revenue in Exosome Proteomics Service Business (2021–2026)

11.9.5 Sistemic Recent Development

11.10 Exosome Diagnostics

11.10.1 Exosome Diagnostics Company Details

11.10.2 Exosome Diagnostics Business Overview

11.10.3 Exosome Diagnostics Exosome Proteomics Service Introduction

11.10.4 Exosome Diagnostics Revenue in Exosome Proteomics Service Business (2021–2026)

11.10.5 Exosome Diagnostics Recent Development

11.11 Lonza Group

11.11.1 Lonza Group Company Details

11.11.2 Lonza Group Business Overview

11.11.3 Lonza Group Exosome Proteomics Service Introduction

11.11.4 Lonza Group Revenue in Exosome Proteomics Service Business (2021–2026)

11.11.5 Lonza Group Recent Development

11.12 Evox Therapeutics

11.12.1 Evox Therapeutics Company Details

11.12.2 Evox Therapeutics Business Overview

11.12.3 Evox Therapeutics Exosome Proteomics Service Introduction

11.12.4 Evox Therapeutics Revenue in Exosome Proteomics Service Business (2021–2026)

11.12.5 Evox Therapeutics Recent Development

11.13 Evomic Science

11.13.1 Evomic Science Company Details

11.13.2 Evomic Science Business Overview

11.13.3 Evomic Science Exosome Proteomics Service Introduction

11.13.4 Evomic Science Revenue in Exosome Proteomics Service Business (2021–2026)

11.13.5 Evomic Science Recent Development

11.14 Optofluidics

11.14.1 Optofluidics Company Details

11.14.2 Optofluidics Business Overview

11.14.3 Optofluidics Exosome Proteomics Service Introduction

11.14.4 Optofluidics Revenue in Exosome Proteomics Service Business (2021–2026)

11.14.5 Optofluidics Recent Development

11.15 New England Biolabs

11.15.1 New England Biolabs Company Details

11.15.2 New England Biolabs Business Overview

11.15.3 New England Biolabs Exosome Proteomics Service Introduction

11.15.4 New England Biolabs Revenue in Exosome Proteomics Service Business (2021–2026)

11.15.5 New England Biolabs Recent Development

11.16 Izon Science

11.16.1 Izon Science Company Details

11.16.2 Izon Science Business Overview

11.16.3 Izon Science Exosome Proteomics Service Introduction

11.16.4 Izon Science Revenue in Exosome Proteomics Service Business (2021–2026)

11.16.5 Izon Science Recent Development

11.17 Miltenyi Biotec

11.17.1 Miltenyi Biotec Company Details

11.17.2 Miltenyi Biotec Business Overview

11.17.3 Miltenyi Biotec Exosome Proteomics Service Introduction

11.17.4 Miltenyi Biotec Revenue in Exosome Proteomics Service Business (2021–2026)

11.17.5 Miltenyi Biotec Recent Development

11.18 Codiak BioSciences

11.18.1 Codiak BioSciences Company Details

11.18.2 Codiak BioSciences Business Overview

11.18.3 Codiak BioSciences Exosome Proteomics Service Introduction

11.18.4 Codiak BioSciences Revenue in Exosome Proteomics Service Business (2021–2026)

11.18.5 Codiak BioSciences Recent Development

11.19 Ology Bioservices

11.19.1 Ology Bioservices Company Details

11.19.2 Ology Bioservices Business Overview

11.19.3 Ology Bioservices Exosome Proteomics Service Introduction

11.19.4 Ology Bioservices Revenue in Exosome Proteomics Service Business (2021–2026)

11.19.5 Ology Bioservices Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

HansaBioMed Life Sciences

List of Tables

Table 1. Global Exosome Proteomics Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Separation

Table 3. Key Players of Identification and Characterization

Table 4. Key Players of Quantitative Analysis

Table 5. Key Players of Content Analysis

Table 6. Key Players of Functional Analysis

Table 7. Global Exosome Proteomics Service Market Size Growth Rate by Technical Methods (US$ Million): 2021 vs 2025 vs 2032

Table 8. Key Players of Mass Spectrometry-driven

Table 9. Key Players of Non-mass Spectrometry-dependent

Table 10. Global Exosome Proteomics Service Market Size Growth Rate by Analysis Granularity (US$ Million): 2021 vs 2025 vs 2032

Table 11. Key Players of Whole Proteome Scanning

Table 12. Key Players of Targeted Sub-proteome

Table 13. Global Exosome Proteomics Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global Exosome Proteomics Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 15. Global Exosome Proteomics Service Market Size by Region (US$ Million), 2021–2026

Table 16. Global Exosome Proteomics Service Market Share by Region (2021–2026)

Table 17. Global Exosome Proteomics Service Forecasted Market Size by Region (US$ Million), 2027–2032

Table 18. Global Exosome Proteomics Service Market Share by Region (2027–2032)

Table 19. Exosome Proteomics Service Market Trends

Table 20. Exosome Proteomics Service Market Drivers

Table 21. Exosome Proteomics Service Market Challenges

Table 22. Exosome Proteomics Service Market Restraints

Table 23. Global Exosome Proteomics Service Revenue by Players (US$ Million), 2021–2026

Table 24. Global Exosome Proteomics Service Market Share by Players (2021–2026)

Table 25. Global Top Exosome Proteomics Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Exosome Proteomics Service Revenue, 2025

Table 26. Ranking of Global Top Exosome Proteomics Service Companies by Revenue (US$ Million) in 2025

Table 27. Global 5 Largest Players Market Share by Exosome Proteomics Service Revenue (CR5 and HHI), 2021–2026

Table 28. Global Key Players of Exosome Proteomics Service, Headquarters and Area Served

Table 29. Global Key Players of Exosome Proteomics Service, Products and Applications

Table 30. Global Key Players of Exosome Proteomics Service, Date of General Availability (GA)

Table 31. Mergers and Acquisitions, Expansion Plans

Table 32. Global Exosome Proteomics Service Market Size by Type (US$ Million), 2021–2026

Table 33. Global Exosome Proteomics Service Revenue Market Share by Type (2021–2026)

Table 34. Global Exosome Proteomics Service Forecasted Market Size by Type (US$ Million), 2027–2032

Table 35. Global Exosome Proteomics Service Revenue Market Share by Type (2027–2032)

Table 36. Global Exosome Proteomics Service Market Size by Application (US$ Million), 2021–2026

Table 37. Global Exosome Proteomics Service Revenue Market Share by Application (2021–2026)

Table 38. Global Exosome Proteomics Service Forecasted Market Size by Application (US$ Million), 2027–2032

Table 39. Global Exosome Proteomics Service Revenue Market Share by Application (2027–2032)

Table 40. North America Exosome Proteomics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. North America Exosome Proteomics Service Market Size by Country (US$ Million), 2021–2026

Table 42. North America Exosome Proteomics Service Market Size by Country (US$ Million), 2027–2032

Table 43. Europe Exosome Proteomics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Europe Exosome Proteomics Service Market Size by Country (US$ Million), 2021–2026

Table 45. Europe Exosome Proteomics Service Market Size by Country (US$ Million), 2027–2032

Table 46. Asia-Pacific Exosome Proteomics Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 47. Asia-Pacific Exosome Proteomics Service Market Size by Region (US$ Million), 2021–2026

Table 48. Asia-Pacific Exosome Proteomics Service Market Size by Region (US$ Million), 2027–2032

Table 49. Latin America Exosome Proteomics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 50. Latin America Exosome Proteomics Service Market Size by Country (US$ Million), 2021–2026

Table 51. Latin America Exosome Proteomics Service Market Size by Country (US$ Million), 2027–2032

Table 52. Middle East & Africa Exosome Proteomics Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 53. Middle East & Africa Exosome Proteomics Service Market Size by Country (US$ Million), 2021–2026

Table 54. Middle East & Africa Exosome Proteomics Service Market Size by Country (US$ Million), 2027–2032

Table 55. System Biosciences Company Details

Table 56. System Biosciences Business Overview

Table 57. System Biosciences Exosome Proteomics Service Product

Table 58. System Biosciences Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 59. System Biosciences Recent Development

Table 60. HansaBioMed Life Sciences Company Details

Table 61. HansaBioMed Life Sciences Business Overview

Table 62. HansaBioMed Life Sciences Exosome Proteomics Service Product

Table 63. HansaBioMed Life Sciences Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 64. HansaBioMed Life Sciences Recent Development

Table 65. QIAGEN Company Details

Table 66. QIAGEN Business Overview

Table 67. QIAGEN Exosome Proteomics Service Product

Table 68. QIAGEN Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 69. QIAGEN Recent Development

Table 70. Norgen Biotek Company Details

Table 71. Norgen Biotek Business Overview

Table 72. Norgen Biotek Exosome Proteomics Service Product

Table 73. Norgen Biotek Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 74. Norgen Biotek Recent Development

Table 75. Bio-Techne Company Details

Table 76. Bio-Techne Business Overview

Table 77. Bio-Techne Exosome Proteomics Service Product

Table 78. Bio-Techne Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 79. Bio-Techne Recent Development

Table 80. AMSBIO Company Details

Table 81. AMSBIO Business Overview

Table 82. AMSBIO Exosome Proteomics Service Product

Table 83. AMSBIO Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 84. AMSBIO Recent Development

Table 85. NX Pharmagen Company Details

Table 86. NX Pharmagen Business Overview

Table 87. NX Pharmagen Exosome Proteomics Service Product

Table 88. NX Pharmagen Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 89. NX Pharmagen Recent Development

Table 90. Thermo Fisher Scientific Company Details

Table 91. Thermo Fisher Scientific Business Overview

Table 92. Thermo Fisher Scientific Exosome Proteomics Service Product

Table 93. Thermo Fisher Scientific Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 94. Thermo Fisher Scientific Recent Development

Table 95. Sistemic Company Details

Table 96. Sistemic Business Overview

Table 97. Sistemic Exosome Proteomics Service Product

Table 98. Sistemic Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 99. Sistemic Recent Development

Table 100. Exosome Diagnostics Company Details

Table 101. Exosome Diagnostics Business Overview

Table 102. Exosome Diagnostics Exosome Proteomics Service Product

Table 103. Exosome Diagnostics Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 104. Exosome Diagnostics Recent Development

Table 105. Lonza Group Company Details

Table 106. Lonza Group Business Overview

Table 107. Lonza Group Exosome Proteomics Service Product

Table 108. Lonza Group Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 109. Lonza Group Recent Development

Table 110. Evox Therapeutics Company Details

Table 111. Evox Therapeutics Business Overview

Table 112. Evox Therapeutics Exosome Proteomics Service Product

Table 113. Evox Therapeutics Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 114. Evox Therapeutics Recent Development

Table 115. Evomic Science Company Details

Table 116. Evomic Science Business Overview

Table 117. Evomic Science Exosome Proteomics Service Product

Table 118. Evomic Science Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 119. Evomic Science Recent Development

Table 120. Optofluidics Company Details

Table 121. Optofluidics Business Overview

Table 122. Optofluidics Exosome Proteomics Service Product

Table 123. Optofluidics Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 124. Optofluidics Recent Development

Table 125. New England Biolabs Company Details

Table 126. New England Biolabs Business Overview

Table 127. New England Biolabs Exosome Proteomics Service Product

Table 128. New England Biolabs Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 129. New England Biolabs Recent Development

Table 130. Izon Science Company Details

Table 131. Izon Science Business Overview

Table 132. Izon Science Exosome Proteomics Service Product

Table 133. Izon Science Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 134. Izon Science Recent Development

Table 135. Miltenyi Biotec Company Details

Table 136. Miltenyi Biotec Business Overview

Table 137. Miltenyi Biotec Exosome Proteomics Service Product

Table 138. Miltenyi Biotec Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 139. Miltenyi Biotec Recent Development

Table 140. Codiak BioSciences Company Details

Table 141. Codiak BioSciences Business Overview

Table 142. Codiak BioSciences Exosome Proteomics Service Product

Table 143. Codiak BioSciences Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 144. Codiak BioSciences Recent Development

Table 145. Ology Bioservices Company Details

Table 146. Ology Bioservices Business Overview

Table 147. Ology Bioservices Exosome Proteomics Service Product

Table 148. Ology Bioservices Revenue in Exosome Proteomics Service Business (US$ Million), 2021–2026

Table 149. Ology Bioservices Recent Development

Table 150. Research Programs/Design for This Report

Table 151. Key Data Information from Secondary Sources

Table 152. Key Data Information from Primary Sources

Table 153. Authors List of This Report

List of Figures

Figure 1. Exosome Proteomics Service Picture

Figure 2. Global Exosome Proteomics Service Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Exosome Proteomics Service Market Share by Type: 2025 vs 2032

Figure 4. Separation Features

Figure 5. Identification and Characterization Features

Figure 6. Quantitative Analysis Features

Figure 7. Content Analysis Features

Figure 8. Functional Analysis Features

Figure 9. Global Exosome Proteomics Service Market Size Comparison by Technical Methods (US$ Million), 2021–2032

Figure 10. Mass Spectrometry-driven Features

Figure 11. Non-mass Spectrometry-dependent Features

Figure 12. Global Exosome Proteomics Service Market Size Comparison by Analysis Granularity (US$ Million), 2021–2032

Figure 13. Whole Proteome Scanning Features

Figure 14. Targeted Sub-proteome Features

Figure 15. Global Exosome Proteomics Service Market Size by Application (US$ Million), 2021–2032

Figure 16. Global Exosome Proteomics Service Market Share by Application: 2025 vs 2032

Figure 17. Financial Industry Case Studies

Figure 18. Government Sector Case Studies

Figure 19. Media Organizations Case Studies

Figure 20. E-commerce and Retail Case Studies

Figure 21. Others Case Studies

Figure 22. Exosome Proteomics Service Report Years Considered

Figure 23. Global Exosome Proteomics Service Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 24. Global Exosome Proteomics Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global Exosome Proteomics Service Market Share by Region: 2025 vs 2032

Figure 26. Global Exosome Proteomics Service Market Share by Players in 2025

Figure 27. Global Exosome Proteomics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by Exosome Proteomics Service Revenue in 2025

Figure 29. North America Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. North America Exosome Proteomics Service Market Share by Country (2021–2032)

Figure 31. United States Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Canada Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Europe Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe Exosome Proteomics Service Market Share by Country (2021–2032)

Figure 35. Germany Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. France Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. U.K. Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Italy Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Russia Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Ireland Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Asia-Pacific Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific Exosome Proteomics Service Market Share by Region (2021–2032)

Figure 43. China Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Japan Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. South Korea Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Southeast Asia Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. India Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Australia & New Zealand Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Latin America Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America Exosome Proteomics Service Market Share by Country (2021–2032)

Figure 51. Mexico Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Brazil Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Middle East & Africa Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa Exosome Proteomics Service Market Share by Country (2021–2032)

Figure 55. Israel Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Saudi Arabia Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. UAE Exosome Proteomics Service Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. System Biosciences Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 59. HansaBioMed Life Sciences Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 60. QIAGEN Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 61. Norgen Biotek Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 62. Bio-Techne Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 63. AMSBIO Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 64. NX Pharmagen Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 66. Sistemic Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 67. Exosome Diagnostics Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 68. Lonza Group Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 69. Evox Therapeutics Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 70. Evomic Science Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 71. Optofluidics Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 72. New England Biolabs Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 73. Izon Science Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 74. Miltenyi Biotec Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 75. Codiak BioSciences Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 76. Ology Bioservices Revenue Growth Rate in Exosome Proteomics Service Business (2021–2026)

Figure 77. Bottom-up and Top-down Approaches for This Report

Figure 78. Data Triangulation

Figure 79. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions